Tower Research Capital LLC (TRC) - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 26 filers reported holding INMUNE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$17,217
+20.8%
2,543
+62.0%
0.00%
Q2 2023$14,256
+109561.5%
1,570
-22.9%
0.00%
Q1 2023$13
+30.0%
2,037
+35.5%
0.00%
Q4 2022$10
-100.0%
1,503
-61.6%
0.00%
Q3 2022$25,000
-66.7%
3,909
-46.5%
0.00%
-100.0%
Q4 2021$75,000
+200.0%
7,306
+421.5%
0.00%0.0%
Q2 2021$25,000
-84.3%
1,401
-89.5%
0.00%
-66.7%
Q1 2021$159,000
+2550.0%
13,365
+2127.5%
0.00%
Q3 2020$6,000
-14.3%
600
-55.7%
0.00%
Q2 2020$7,000
+600.0%
1,355
+564.2%
0.00%
Q3 2019$1,0002040.00%
Other shareholders
INMUNE BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 178,284$1,219,4630.13%
Fermata Advisors, LLC 56,702$383,8880.11%
Westside Investment Management, Inc. 41,540$281,2270.08%
QUADRANT CAPITAL GROUP LLC 60,000$406,2000.04%
MAI Capital Management 97,410$659,4660.01%
Janney Montgomery Scott LLC 256,887$1,7390.01%
Financial Advocates Investment Management 11,510$78,3200.01%
VALLEY NATIONAL ADVISERS INC 1,000$70.00%
Beacon Pointe Advisors, LLC 10,368$70,1910.00%
Asset Dedication, LLC 814$60.00%
View complete list of INMUNE BIO INC shareholders